Olmesartan Medoxomil 20/10 Milligrams
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
White Life Sciences Co., Ltd.
MFDS item code 202003969 · Approved 2020.05.28
This product's status changed to Expired on 2025.05.28. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of hypertension, improvement of dyslipidemia, inhibition of atherosclerotic progression and cardiovascular risk
This medication is used for patients who need to take both olmesartan medoxomil and rosuvastatin. Olmesartan medoxomil primarily helps to control blood pressure in patients with essential hypertension. Rosuvastatin is used as an adjunct for various types of hyperlipidemia, especially when dietary measures and exercise alone are not sufficient to control primary hypercholesterolemia and mixed hyperlipidemia. It is also used as an adjunct to dietary measures in patients with homozygous familial hypercholesterolemia and primary dysbetalipoproteinemia, lowering total cholesterol and LDL cholesterol to delay the progression of atherosclerosis. Additionally, it is effective in reducing the risk of cardiovascular disease, stroke, myocardial infarction, and complications after vascular interventions in adult patients with certain risk factors. Thus, this medication is used to manage both hypertension and hyperlipidemia and reduce cardiovascular risks.
This medicine is for adults only. The dose should be individualized for each patient based on the effects and tolerability of each of the active ingredients, olmesartan medoxomil and rosuvastatin. ◆ Olmesartan medoxomil 1. Adults The recommended initial dose is 10mg once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood-pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum at about 8 weeks. If blood pressure is not controlled with this medicine alone, it may be given in combination with a thiazide diuretic, such as hydrochlorothiazide. To improve adherence, it is recommended that the medicine be taken at the same time each day (e.g., in the morning), if possible. For patients who may have reduced effective intravascular volume (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended that treatment be initiated at a low dose with close monitoring of their condition. 2. Elderly patients No dose adjustment is needed when this medicine is administered to patients aged 65 years or older. Although no overall differences in efficacy or safety have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. 3. Patients with renal impairment The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20mg once daily. 4. Patients with hepatic impairment No dose adjustment is needed for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and it may be increased to a maximum of 20mg daily. Since there is no experience with use in patients with severe hepatic impairment, administration of this medicine is not recommended. ◆ Rosuvastatin 1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, and most patients are controlled at this dose. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; it may be increased to a maximum of 20 milligrams daily. 2. Elderly patients No dose adjustment is needed. 3. Patients with renal impairment No dose adjustment is needed for patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients. Patients taking olmesartan medoxomil and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.
Safety and efficacy have not been established in children under 18 years of age.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, therefore it must be stopped immediately if pregnancy is confirmed. This medication should not be taken by those with hypersensitivity to it, pregnant or potentially pregnant women, or nursing mothers. Patients with severely impaired kidney function or those undergoing kidney dialysis, patients with severe liver disease, or those with biliary obstruction should not use this medication. Patients at high risk for muscle disease or myopathy should be cautious as muscle-related side effects may worsen when taking this medication. This medication contains lactose; therefore, patients with lactose intolerance or related genetic disorders should not take it. Patients with low blood volume or salt deficiency may experience hypotension upon initial intake; therefore, their condition should be closely monitored. Patients with weak kidney function or those who have received kidney transplants should have their kidney function and electrolyte levels regularly checked through blood tests. Due to the risk of hyperkalemia, blood potassium levels should be monitored regularly, especially in patients with heart failure or kidney disease. Dizziness may occur while taking this medication; therefore, driving or operating hazardous machinery should be avoided. Patients with liver dysfunction or a history of liver disease should have their liver function tested regularly before and during treatment with this medication. If symptoms such as muscle pain or weakness occur, medical attention should be sought immediately, and this medication may need to be stopped if necessary. The risk of side effects may increase with interactions when taking this medication with other drugs; therefore, patients must inform their doctors or pharmacists of any current medications. This medication is not recommended for pregnant or nursing women, and women of childbearing age should use adequate contraceptive measures. The safety and efficacy in children and adolescents under 18 years of age have not been established; caution is advised in their use. Elderly patients may experience increased plasma concentrations of this medication; therefore, dose adjustments and monitoring for side effects are recommended. In cases of overdose, symptoms such as hypotension and palpitations may occur, and as there is no specific antidote, treatment should be provided according to the symptoms. This medication should be kept out of reach of children, and transferring it to another container should be avoided.
Increased ALT, Increased AST, Increased blood creatinine, Decreased creatinine clearance, Headache, Dizziness, Sensory impairment, Neuromyopathy, Drowsiness, Reflux esophagitis, Constipation, Tooth decay, Indigestion, Stomach ulcer, Gastritis, Gastroenteritis, Musculoskeletal stiffness, Atrial fibrillation, Hypoglycemia, Chest pain, Tooth extraction, Chest pain, Peripheral edema, Dizziness, Abdominal pain, Nausea, Palpitations, Hypercholesterolemia, Hyperlipidemia, Hyperuricemia, Arthralgia, Arthritis, Myalgia, Rash, Facial edema, Asthenia, Vascular edema, Anaphylactic reaction, Vomiting, Chronic malabsorption syndrome, Rhabdomyolysis, Hyperkalemia, Acute renal failure, Hair loss, Itching, Urticaria, Autoimmune hepatitis, Positional vertigo, Increased blood pressure, Increased blood creatinine, Cough, Epistaxis, Upper respiratory infection, Asthma, Hypersensitivity reaction including vascular edema, Diabetes, Pancreatitis, Itching, Rash, Urticaria, Myalgia, Myopathy, Rhabdomyolysis, Asthenia, Polyneuropathy, Amnesia, Peripheral neuropathy, Dyspnea, Diarrhea, Thrombocytopenia, Jaundice, Hepatitis, Stevens-Johnson syndrome, Drug reaction with eosinophilia and systemic symptoms syndrome, Lupus-like syndrome, Muscle rupture, Immune-mediated necrotizing myopathy, Hematuria, Edema, Depression, Sleep disorders, Interstitial lung disease, Sexual dysfunction, Gynecomastia, Fatal and non-fatal liver failure, Cognitive impairment, Severe myasthenia, Ocular myasthenia
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is essential to maintain the storage temperature between 1 and 30 degrees Celsius. This will help keep the medication effective for a long time.
White or off-white round film-coated tablets
30 tablets (10 tablets/Alu-Alu) x 3
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Olmesartan Medoxomil 20mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
White Life Sciences Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 20mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd. Daewoong Pharmaceutical)
CombinationRosuvastatin Calcium 5.2mg · Olmesartan Medoxomil 10mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Daewoong Pharmaceutical
CombinationRosuvastatin Calcium 10.4mg · Olmesartan Medoxomil 40mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.